Figure 1
Complete clinical response in a patient with locally advanced high-grade microsatellite instability/deficiency in mismatch repair rectal adenocarcinoma after short-course ipilimumab and nivolumab. (A): Endoscopic imaging, showing a bleeding rectal cancer 9 cm from the anal verge in a 33-year-old male patient with Lynch syndrome. (B): Magnetic resonance imaging (MRI) staging demonstrated a locally advanced rectal cancer (cT3 cN2 cM0). (C): Endoscopy and (D) MRI demonstrating a complete clinical response after short-course treatment with ipilimumab and nivolumab.

Complete clinical response in a patient with locally advanced high-grade microsatellite instability/deficiency in mismatch repair rectal adenocarcinoma after short-course ipilimumab and nivolumab. (A): Endoscopic imaging, showing a bleeding rectal cancer 9 cm from the anal verge in a 33-year-old male patient with Lynch syndrome. (B): Magnetic resonance imaging (MRI) staging demonstrated a locally advanced rectal cancer (cT3 cN2 cM0). (C): Endoscopy and (D) MRI demonstrating a complete clinical response after short-course treatment with ipilimumab and nivolumab.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close